BioHarvest Sciences Inc. ... (BHST)
NASDAQ: BHST
· Real-Time Price · USD
7.35
-0.31 (-4.07%)
At close: Jun 13, 2025, 3:59 PM
7.56
2.86%
After-hours: Jun 13, 2025, 07:49 PM EDT
BioHarvest Sciences Common Stock Revenue Breakdown
| Period Ending | Dec 31, 2024 |
|---|---|
| Products Revenue | 24.91M |
| Products Revenue Growth | n/a |
| Total Revenue | 25.19M |
| Total Revenue Growth | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2024 |
|---|---|
| Israel Revenue | 2.18M |
| Israel Revenue Growth | n/a |
| North America Revenue | 23.01M |
| North America Revenue Growth | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Jan 31, 2020 | Oct 31, 2019 | Jul 31, 2019 | Apr 30, 2019 | Jan 31, 2019 | Oct 31, 2018 | Jul 31, 2018 | Apr 30, 2018 | Jan 31, 2018 | Oct 31, 2017 | Jul 31, 2017 | Apr 30, 2017 | Jan 31, 2017 | Oct 31, 2016 | Jul 31, 2016 | Apr 30, 2016 | Jan 31, 2016 | Oct 31, 2015 | Jul 31, 2015 | Apr 30, 2015 | Jan 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 5.05M | 4.01M | 4.54M | 3.79M | 3.39M | 3.63M | 2.56M | 3.17M | 2.72M | 2.46M | 2.7M | 2.15M | 2.04M | 1.24M | 2.07M | 1.78M | 1.67M | 1.98M | 1.25M | 586K | 500K | 199K | 327K | 212K | -1.12M | n/a | n/a | n/a | 52.73K | n/a | n/a | n/a | 31.14K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 87.35K | n/a |
| Selling, General, and Administrative Revenue Growth | +25.90% | -11.55% | +19.74% | +11.70% | -6.63% | +42.23% | -19.38% | +16.68% | +10.23% | -8.64% | +25.44% | +5.34% | +64.09% | -39.83% | +15.99% | +6.83% | -15.76% | +58.65% | +112.97% | +17.20% | +151.26% | -39.14% | +54.25% | -119.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -100.00% | n/a | n/a |
| Research and Development Revenue | 1.24M | 1.4M | 1.28M | 1.09M | 1.03M | 1.05M | 894K | 812K | 611.05K | 568K | 554K | 415K | 771K | 1.93M | 814K | 724K | 650K | 371K | 351K | 282K | 260K | 467K | 471K | 446K | n/a | 812K | 36K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | -11.15% | +9.31% | +17.46% | +5.22% | -1.71% | +17.67% | +10.10% | +32.89% | +7.58% | +2.53% | +33.49% | -46.17% | -60.14% | +137.65% | +12.43% | +11.38% | +75.20% | +5.70% | +24.47% | +8.46% | -44.33% | -0.85% | +5.61% | n/a | -100.00% | +2155.56% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |